Mirage News·3 min read·medium
HIV Vaccine Achieves Breakthrough in Preclinical Study
✦AI Summary
Scientists at the La Jolla Institute for Immunology and Scripps Research have developed a new HIV vaccine that successfully triggers broadly neutralizing antibodies in primates. The vaccine, which has now entered human trials, represents a significant advancement in the 14-year effort to combat the virus.
Scientists at La Jolla Institute for Immunology and Scripps Research have developed an HIV vaccine that trains immune cells to see past HIV's defenses.
sciencehealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in